by Marion Nestle

Currently browsing posts about: Antioxidants

Jan 15 2024

Industry-funded study of the week: antioxidant supplement and sperm quality

Here’s where I first saw this one: Antioxidant supplement improves sperm quality and pregnancy outcomes, research suggests: Supplementing men with a combination of micronutrients and L-Carnitine shows promise in improving sperm motility and pregnancy outcomes, a new study concludes…. Read more

I could not wait to fsee the research.

The study:  Effect of Micronutrients and L-Carnitine as Antioxidant on Sperm Parameters, Genome Integrity, and ICSI Outcomes: Randomized, Double-Blind, and Placebo-Controlled Clinical Trial. Antioxidants 2023, 12(11), 1937https://doi.org/10.3390/antiox12111937

Rationale: Oxidative stress has been identified as a crucial factor leading to genome decay, lipid peroxidation, and nucleoprotein oxidation.

Method: double-blind, placebo-controlled clinical trial aimed to assess the effect of oral antioxidant treatment (Fertilis), which contains L-carnitine and some micronutrients, in the improvement of conventional sperm parameters, sperm DNA integrity and in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes.

Results: The study outcome revealed a significant decrease in the DNA fragmentation index and a significant increase in sperm motility after 3 months of treatment (p = 0.01 and p = 0.02, respectively). Additionally, a significant improvement in clinical pregnancy rate (p = 0.01) and life birth rate (p = 0.031) was observed. No significant changes were observed in conventional sperm parameters (volume, count, and vitality) or sperm DNA decondensation (SDI).

Conclusion: Antioxidant therapy has a beneficial impact on achieving pregnancy, whether through spontaneous conception or assisted reproductive procedures (ART).

Funding: This research received received funding from the MEDIS laboratories.

Acknowledgments: The authors wish to thank MEDIS laboratories, especially Mohamed Bouchoucha “the general director”, Sonia Hafaiedh “the Medical laboratory director”, Sami Bousetta “the clinical research associate”, and Anis Ghribi “the data manager” for the encouragement and support….

Conflicts of Interest: The authors declare no conflict of interest.

Comment: The funder, Medis, is the maker of “High quality generic pharmaceuticals” like this supplement, no doubt.  Even though the supplement had no effect on the usual measures of sperm number and viability, women who took the suipplessment did better in achieving pregnancy.  I’d say more research needed on this one.  In the meantime, if you believe this result and want to up your sperm quality, eat your veggies!  Practically any fruit or vegetable is rich in antioxidants. Eat the ones you like.

As for “no conflicts of interest.” I respectfully disagree.  Funding from a company that stands to gain from a positive result clearly introduces conflicted interests.

Feb 13 2023

Industry-funded study of the week: Astaxanthin

Astaxanthin is the dye used by growers of farmed salmon to give the fish a pink color.  They do this by matching the desired amount of the dye to this SalmoFan template.

Astaxanthin, claim its makers, is an antioxidant and, therefore, good for you.

First the public relations: Screen shot: Astaxanthin reduces work-induced visual stress in people aged over 40 – BGG trial: Astaxanthin supplementation has been found to reduce visual display terminal (VDT) work-induced visual stress in people aged over 40, according to a new Japan trial sponsored by supplier BGG Japan. Read more

As for the actual research:

The study: Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study.  Takahiro SekikawaYuki KizawaYanmei LiNaoki Miura. J Clin Biochem Nutr.  https://doi.org/10.3164/jcbn.22-65.

Results:  In participants aged ≥40 years, corrected visual acuity of the dominant eye after visual display terminal work at 6 weeks after intake demonstrated a higher protective effect of astaxanthin in the astaxanthin group vs the control group (p<0.05). In participants aged <40 years, no significant difference was seen between the astaxanthin and control groups. Moreover, no significant difference was found in functional visual acuity and pupil constriction rate between the astaxanthin and control groups [my emphasis].

Conclusion: These results suggest astaxanthin reduces oxidative stress caused by visual display terminal work. Age-related reduction in ciliary muscle strength is likely the main detractor of visual acuity. Correspondingly, astaxanthin reduced visual display terminal work-induced visual stress in the middleaged and elderly.

Conflict of interest: This trial was sponsored by BGG Japan Co., Ltd., which provided all costs for the implementation of the trial. TS and YK are employees of BGG Japan Co., Ltd. YL is an employee of Beijing Gingko-Group Biological Technology Co., Ltd., which belongs to the same company group as BGG Japan Co., Ltd. NM received funding from BGG Japan Co., Ltd. to provide medical services to the trial participants.

Comment: BGG makes astaxanthin products.  This is a company-sponsored study conducted by researchers employed or paid by the company.  It is an excellent example of interpretation bias—putting a positive spin on results that are marginally significant in some groups but not others, or null.

*******

For 30% off, go to www.ucpress.edu/9780520384156.  Use code 21W2240 at checkout.

 

Jun 3 2019

Industry-funded study of the week: blueberries again

I love blueberries and grow two different kinds on my 12th-floor Manhattan terrace, both delicious if I can get to them before the voracious birds do.

I wish the blueberry industry could just accept delicious and leave it at that, but no such luck.  It is desperate to get research it can use to promote blueberries as a superfruit (I wrote about the history of blueberry-funded research in Unsavory Truth).

Here’s the latest.

The study: Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome—results from a 6-month, double-blind, randomized controlled trial.  Peter J Curtis, et al. Am J Clin Nutr 2019;109:1535–1545.

Method: Participants were fed powdered blueberries equivalent to a half or full cup a day, compared to placebo.

Conclusions: Despite insulin resistance remaining unchanged we show, to our knowledge, the first sustained improvements in vascular function, lipid status, and underlying NO [nitric oxide] bioactivity following 1cup blueberries/d. With effect sizes predictive of 12–15% reductions in CVD risk, blueberries should be included in dietary strategies to reduce individual and population CVD risk.

Funder: Supported by the US Highbush Blueberry Council (USHBC) with oversight from the USDA and the Biotechnology and Biological Sciences Research Council (BBSRC, UK). AC and ERB both act as advisors to the USHBC grant committee. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Comment: The press picked this one up:  “Study: Blueberries benefit heart health.”  This study used powdered blueberries.  Trust me, the fresh ones are much better.  You can tell this is an industry-funded study because the published study is open access, which somebody has to pay for—a clue that it is about marketing.  And what about the comment that funders had no influence?  They didn’t have to.  The study did not compare blueberries to any other fruits.  The science here provides some interesting information about how anthocyanins in this fruit might work, but wouldn’t they work the same way in any other fruit?  Are blueberries the only fruit that contains these particular anthocyanins?   This questions suggest that this study is not about the science, it is about demonstrating that there is something special about blueberries.  Dietary advice?  Eat whatever fruits you like.  And vegetables.  And nuts.  They all have something good about them.

 

Jun 4 2013

Questions about food politics: iPhone apps and phytonutrients

I’m always happy to answer questions dealing with issues related to food politics.  Here are responses to two that came in last week.  I’ll do another two sometime this week. 

Q1.  I was just introduced to your book, What to Eat, and I read it, cover to cover, thoroughly enjoying each area of the market.  I am emailing in hopes that you have a suggested iPhone App, which suggests or promotes healthy eating.  Not so much calorie counter Apps, but Apps which make suggestions towards healthier options or perhaps even suggests macro or micronutrients which we may be lacking based on the foods we are purchasing and consuming.  Any help is much appreciated!  Thanks!

A.  I’m a diehard BlackBerry user and haven’t a clue.  Readers: suggestions?

Q2.  I’m an NYU MPH student and will probably be taking your Food Advocacy class next spring.  I adore your blog and as of late have been especially appreciative of your Farm Bill breakdowns. (What a confusing document!)  I was wondering what your take was on the NYTimes article that appeared in the Week in Review on Sunday titled, “Breeding the Nutrition out of Our Food” by Jo Robinson.  Have we really been losing the phytonutrients in our food since we became farmers?

A.  Ms. Robinson, whose terrific new book, “Eating on the Wild Side” is out this week, collected data on phytonutrient (plant antioxidant) levels in wild foods and their bred-to-be-less-bitter supermarket counterparts.  The wild ones have more, but they usually don’t taste as good.  The idea that foods now are less nutritious than foods in the past fits conveniently with concerns about our industrialized food system.  But data on trends in nutrient content are difficult to come by (the methods change over time), and differences in health benefits are impossible to assess.  The bottom line: people who eat fruits and vegetables—even supermarket varieties—are healthier than people who don’t.  Would they be even healthier if the vegetables were more bitter because of the phytonutrients?  Hard to say.  I’m going to eat my veggies and not worry about this one.

Nov 23 2009

You heard it here: the hot trend is cupuaçu (?)

What, you may well ask, is cupuaçu?  I confess never having heard of it but thank heavens for Wikipedia, which explains in somewhat limited detail that it is a chocolate-like tree with a sweet fruit.  Botanically, it is a Theobroma in the chocolate family.

Mintel, the market research firm, identifies it as the newest antioxidant-rich fruit craze.  It says this fruit is not only rich in antioxidants, but also in vitamins, essential fatty acids and amino acids.  Well, yes, but so are all fruits to a greater or lesser extent.  But never mind.  Anything this exotic has to be a marketers’ dream “superfruit,” no?

Can’t wait to taste it.  If you know anything about this, do say, especially about how it might taste.

Mintel has six other predictions for upcoming hot trends:  sweet potato, cardamom, rose water, hibiscus, and Latin spices. Yum.  Aren’t you happy to be the first to know?

May 14 2009

Will the FDA start regulating supplements?

If the FDA is now going after health claims (see yesterday’s post), will it also start going after dietary supplements?  These, as I explained in my most recent column in the San Francisco Chronicle, get to make all kinds of unsubstantiated claims without the FDA being able to do much about them.  More and more evidence is coming in suggesting that supplements can be harmful as well as ineffective.   The latest example: antioxidant supplements are said to interfere with the beneficial effects of physical activity.    Will such studies encourage the FDA to insist that manufacturers demonstrate safety and efficacy before they put supplements on the market?  That would be a refreshing change, no?

Apr 16 2009

Europe demands scientific support for health claims. Why can’t we?

The European Food Safety Authority (EFSA) has just rejected a proposal from Merck to allow it to use a health claim stating that omega-3 supplements promote  eye and brain health in infants.  Merck wants moms to take omega-3 supplements during pregnancy and give such supplements to their infants.  EFSA reviewed nearly 90 studies on this topic and concluded that the study results were not “informative.”    In other words, they showed no benefit.  Imagine.  The EFSA demands scientific substantiation of health claims.  I wish we could do that.

Here’s another example from the pomegranate folks.  They do brilliant advertising, but this time the British are complaining that these marketers went too far when they posted billboards stating that pomegranate (“antioxidant powerhouse”) juice will help you cheat death.  The British advertising standards agency balked.  Here too, pesky science gets in the way.  Studies not only fail to support a benefit of antioxidants but sometimes show harm.

Our Congress, however, forces FDA to permit health claims, no matter how absurd.  Try the FDA-allowed “qualified” health claim for omega-3’s: “supportive but not conclusive evidence  shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease” [my emphasis].  The FDA allows omega-3’s to be added to infant formulas, but here’s what it says about them:  “The scientific evidence is mixed…There are no currently available published reports from clinical studies that address whether any long-term beneficial effects exist.”

The EFSA interprets all this as unworthy of a health claim.

What can the FDA do?  If it says there isn’t enough evidence, it gets sued and loses.  The courts tend to rule that food companies can say whatever they like about health benefits on the grounds of free speech and the First Amendment.

In January, the FDA published “guidance” for industry about how it plans to evaluate the scientific basis of health claims.     Guidance is just that.  It is non-binding.

Hello new administration.  How about taking a fresh look at the health claims situation and paying close attention to what regulators in Europe are doing.  How about considering just saying no to health claims.

Mar 30 2009

Antioxidants as a marketing tool

Antioxidant nutrients are so important as marketing tools that they constitute their own brand, say British experts on such questions.  Apparently, up to 60% of consumers who see an antioxidant claim on a product label will buy it for that reason.  Despite lack of evidence that additional antioxidants make people healthier (and may actually do some harm), these claims are so popular that food companies introduced nearly 300 new antioxidant-labeled products into U.S. supermarkets last year.  I’ve been collecting choice examples: breakfast cereals, of course (they are always at the leading edge of nutritional marketing), but also jelly beans.  The marketing has become so competitive that unprocessed fruits and vegetables have to get into the act.  I’ve seen ads for blueberries, tomatoes, and artichokes advertising their high antioxidant content.  Of course they have antioxidants.   All fruits and vegetables contain antioxidants, and theirs may actually do some good.